Acompanhe as Notícias da Recifes

Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial. O recorte ajuda a contextualizar a pauta dentro de Carreira.

Thousands of people begin receiving their first deliveries of once-a-day medication made by Novo NordiskBusiness live – latest updatesA once-a-day Wegovy weight-loss pill has gone on sale at high street and online pharmacies in the UK, but is not yet available on the NHS.Thousand

Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand